Securing vascular access is a wellrecognised technical challenge in paediatric emergency care. Thanks to stable anatomical positioning and relatively simple operation, intraosseous (IO) access needles serve as a vital alternative in rescuing critically ill children, especially neonates, infants and children with severe dehydration. This paper thoroughly discusses the application characteristics and development trends of this technology in paediatric settings.

R&D Background and Clinical Pain Points

Children, particularly infants, have thin blood vessels and thick subcutaneous fat, with marked vascular collapse during circulatory failure, leading to a high failure rate of venipuncture. In addition, children's crying and struggling, together with parental anxiety, further increase operational difficulty. In emergencies such as septic shock, status epilepticus and severe dehydration, delayed medication significantly affects patient prognosis. Intraosseous access technology provides a stable and safe "Plan B" for paediatric emergency care.

Core Technological Innovations

Tailored for paediatric populations, the R&D of intraosseous access needles focuses on the following aspects:

Refined sizing: Needle length and cannula diameter are designed by age and weight groups, balancing puncture depth and flowrate requirements.

Balance between pain relief and safety: Supporting local anaesthesia devices and depthlimiting protection designs reduce the risk of bone injury.

Psychological adaptation: Puncture devices feature soft appearances, and some incorporate cartoon elements to ease children's fear.

Flowrate adaptation: Controllable flowrate connectors are designed according to paediatric cardiopulmonary characteristics to avoid circulatory overload.

Mechanism of Action

Children have thinner bone cortices and highly vascularised medullary cavities, making puncture easier than in adults. Superficial landmarks such as the proximal tibia and distal femur allow easy positioning. After absorption via the medullary cavity, drugs rapidly enter the systemic circulation through the iliac vein and inferior vena cava, achieving effects similar to central venous administration while avoiding vascular injury potentially caused by peripheral venous delivery.

Efficacy Validation

Paediatric clinical studies confirm that:

In children with cardiac arrest, intraosseous access is established significantly faster than venous access.

When infusing antibiotics, anticonvulsants and vasoactive drugs, the time to reach therapeutic blooddrug concentrations shows no difference compared with the venous group.

Complications are mainly local extravasation; severe complications such as compartment syndrome and growthplate injury are rare.

High acceptance is observed among parents and medical staff, especially after repeated failures of conventional venipuncture.

R&D Strategy and Philosophy

The development of paediatric intraosseous access technology follows the philosophy of safety, minimal invasiveness and humancentred care:

Safety: Strict depth limitation and realtime pressure monitoring prevent penetrating injuries.

Minimal invasiveness: Finergauge needles and ultrasoundguided puncture are explored to reduce tissue trauma.

Humancentred care: Attention is paid to operational experience, with accompanying sedation and analgesia regimens to relieve children's psychological trauma.

Future Outlook

Future development directions include:

Development of wearable intraosseous infusion devices to facilitate continuous treatment during paediatric patient transport.

Integration of artificialintelligenceassisted positioning systems to improve firstattempt puncture success rates.

Longterm followup studies to evaluate impacts on bone growth.

Inclusion of the technology into standard Paediatric Advanced Life Support (PALS) protocols and enhanced grassroots training.

Guardians of Paediatric Emergency Care: Core Value of Intraosseous Access Needles in Paediatric Emergencies

Official Release of Findings

Securing vascular access is a wellrecognised technical challenge in paediatric emergency care. Thanks to stable anatomical positioning and relatively simple operation, intraosseous (IO) access needles serve as a vital alternative in rescuing critically ill children, especially neonates, infants and children with severe dehydration. This paper thoroughly discusses the application characteristics and development trends of this technology in paediatric settings.

R&D Background and Clinical Pain Points

Children, particularly infants, have thin blood vessels and thick subcutaneous fat, with marked vascular collapse during circulatory failure, leading to a high failure rate of venipuncture. In addition, children's crying and struggling, together with parental anxiety, further increase operational difficulty. In emergencies such as septic shock, status epilepticus and severe dehydration, delayed medication significantly affects patient prognosis. Intraosseous access technology provides a stable and safe "Plan B" for paediatric emergency care.

Core Technological Innovations

Tailored for paediatric populations, the R&D of intraosseous access needles focuses on the following aspects:

Refined sizing: Needle length and cannula diameter are designed by age and weight groups, balancing puncture depth and flowrate requirements.

Balance between pain relief and safety: Supporting local anaesthesia devices and depthlimiting protection designs reduce the risk of bone injury.

Psychological adaptation: Puncture devices feature soft appearances, and some incorporate cartoon elements to ease children's fear.

Flowrate adaptation: Controllable flowrate connectors are designed according to paediatric cardiopulmonary characteristics to avoid circulatory overload.

Mechanism of Action

Children have thinner bone cortices and highly vascularised medullary cavities, making puncture easier than in adults. Superficial landmarks such as the proximal tibia and distal femur allow easy positioning. After absorption via the medullary cavity, drugs rapidly enter the systemic circulation through the iliac vein and inferior vena cava, achieving effects similar to central venous administration while avoiding vascular injury potentially caused by peripheral venous delivery.

Efficacy Validation

Paediatric clinical studies confirm that:

In children with cardiac arrest, intraosseous access is established significantly faster than venous access.

When infusing antibiotics, anticonvulsants and vasoactive drugs, the time to reach therapeutic blooddrug concentrations shows no difference compared with the venous group.

Complications are mainly local extravasation; severe complications such as compartment syndrome and growthplate injury are rare.

High acceptance is observed among parents and medical staff, especially after repeated failures of conventional venipuncture.

R&D Strategy and Philosophy

The development of paediatric intraosseous access technology follows the philosophy of safety, minimal invasiveness and humancentred care:

Safety: Strict depth limitation and realtime pressure monitoring prevent penetrating injuries.

Minimal invasiveness: Finergauge needles and ultrasoundguided puncture are explored to reduce tissue trauma.

Humancentred care: Attention is paid to operational experience, with accompanying sedation and analgesia regimens to relieve children's psychological trauma.

Future Outlook

Future development directions include:

Development of wearable intraosseous infusion devices to facilitate continuous treatment during paediatric patient transport.

Integration of artificialintelligenceassisted positioning systems to improve firstattempt puncture success rates.

Longterm followup studies to evaluate impacts on bone growth.

Inclusion of the technology into standard Paediatric Advanced Life Support (PALS) protocols and enhanced grassroots training.